Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Fujita

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|September 26, 2022
Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61γ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibodyKei Fujita, Takashi Yao
Journal of Industrial Microbiology & Biotechnology|March 13, 2021
PenA, a penicillin-binding protein-type thioesterase specialized for small peptide cyclizationKenichi Matsuda, Kei Fujita, Toshiyuki Wakimoto
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2023
Chemo-Enzymatic Synthesis of Non-ribosomal Macrolactams by a Penicillin-Binding Protein-Type ThioesteraseMasakazu Kobayashi, Kei Fujita, Kenichi Matsuda, et al.
Journal of the American Chemical Society|January 13, 2023
Streamlined Chemoenzymatic Synthesis of Cyclic Peptides by Non-ribosomal Peptide CyclasesMasakazu Kobayashi, Kei Fujita, Kenichi Matsuda, et al.
Anticancer Research|February 29, 2024
Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia CellsRie Nishi, Kei Fujita, Yasufumi Matsuda, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2023
Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor TreatmentKana Oiwa, Shin Lee, Kei Fujita, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2025
Diol as a New Pantetheine Surrogate for Chemoenzymatic Synthesis of Cyclic Peptides via Nonribosomal Peptide CyclasesKei Fujita, Rintaro Ichihara, Masakazu Kobayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 28, 2023
Filgrastim-induced hemophagocytic lymphohistiocytosis in a patient with mantle cell lymphoma: A case reportSho Higuchi, Shin Lee, Kei Fujita, et al.
Molecular and Clinical Oncology|January 6, 2022
Hypocellular Philadelphia chromosome-positive mixed-phenotype acute leukemia successfully treated with dasatinib: A case reportShin Lee, Kei Fujita, Hiroto Wakayama, et al.
Journal of the American Chemical Society|June 28, 2021
Argicyclamides A-C Unveil Enzymatic Basis for Guanidine Bis-prenylationChin-Soon Phan, Kenichi Matsuda, Nandani Balloo, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|September 26, 2022
Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61γ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibodyKei Fujita, Takashi Yao
Journal of Industrial Microbiology & Biotechnology|March 13, 2021
PenA, a penicillin-binding protein-type thioesterase specialized for small peptide cyclizationKenichi Matsuda, Kei Fujita, Toshiyuki Wakimoto
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2023
Chemo-Enzymatic Synthesis of Non-ribosomal Macrolactams by a Penicillin-Binding Protein-Type ThioesteraseMasakazu Kobayashi, Kei Fujita, Kenichi Matsuda, et al.
Journal of the American Chemical Society|January 13, 2023
Streamlined Chemoenzymatic Synthesis of Cyclic Peptides by Non-ribosomal Peptide CyclasesMasakazu Kobayashi, Kei Fujita, Kenichi Matsuda, et al.
Anticancer Research|February 29, 2024
Polyamine Inhibitor SAM486A Augments Cytarabine Cytotoxicity in Methylthioadenosine Phosphorylase-deficient Leukemia CellsRie Nishi, Kei Fujita, Yasufumi Matsuda, et al.
Internal Medicine (Tokyo, Japan)|July 19, 2023
Clinical Features of Clonal Cytogenetic Abnormalities in Philadelphia-negative Cells Developed During Tyrosine Kinase Inhibitor TreatmentKana Oiwa, Shin Lee, Kei Fujita, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 18, 2025
Diol as a New Pantetheine Surrogate for Chemoenzymatic Synthesis of Cyclic Peptides via Nonribosomal Peptide CyclasesKei Fujita, Rintaro Ichihara, Masakazu Kobayashi, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 28, 2023
Filgrastim-induced hemophagocytic lymphohistiocytosis in a patient with mantle cell lymphoma: A case reportSho Higuchi, Shin Lee, Kei Fujita, et al.
Molecular and Clinical Oncology|January 6, 2022
Hypocellular Philadelphia chromosome-positive mixed-phenotype acute leukemia successfully treated with dasatinib: A case reportShin Lee, Kei Fujita, Hiroto Wakayama, et al.
Journal of the American Chemical Society|June 28, 2021
Argicyclamides A-C Unveil Enzymatic Basis for Guanidine Bis-prenylationChin-Soon Phan, Kenichi Matsuda, Nandani Balloo, et al.
Pageof 4